Compare USB & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USB | SYK |
|---|---|---|
| Founded | 1863 | 1941 |
| Country | United States | United States |
| Employees | N/A | 56000 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.4B | 125.7B |
| IPO Year | 2009 | 1994 |
| Metric | USB | SYK |
|---|---|---|
| Price | $62.05 | $329.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 14 |
| Target Price | $60.28 | ★ $415.57 |
| AVG Volume (30 Days) | ★ 6.0M | 2.2M |
| Earning Date | 04-16-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.70% | 1.12% |
| EPS Growth | ★ 21.90 | 8.25 |
| EPS | 2.53 | ★ 5.23 |
| Revenue | ★ $28,656,000,000.00 | $25,116,000,000.00 |
| Revenue This Year | $16.09 | $9.80 |
| Revenue Next Year | $5.36 | $8.44 |
| P/E Ratio | ★ $24.48 | $62.68 |
| Revenue Growth | 4.37 | ★ 11.16 |
| 52 Week Low | $45.02 | $281.00 |
| 52 Week High | $66.08 | $396.86 |
| Indicator | USB | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 41.43 | 47.54 |
| Support Level | $52.92 | $328.23 |
| Resistance Level | $64.76 | $335.45 |
| Average True Range (ATR) | 1.06 | 8.92 |
| MACD | -0.42 | -2.11 |
| Stochastic Oscillator | 12.35 | 22.20 |
With assets of around $700 billion, U.S. Bancorp is one of the largest regional banks in the US with its footprint in 26 states. The bank's branch network is mostly in Midwestern and Western markets. U.S. Bancorp has a comprehensive product set, with offerings in retail and commercial banking, credit cards, mortgages, payment services, trust, wealth, and capital market services.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.